AABB 2003 Abstracts

Adobe Acrobat required for viewing Abstracts. Download it free here.

To save an abstract, right click, and choose "Save Target As".

• Specificity Analysis of the PROCLEIX^® HIV-1/HCV (Multiplex and Discriminatory) Assay with Source Plasma Donor Samples
• NAT Implementation from A to Z
• Performance of the PROCLEIX^® HIV-1/HCV Assay in Organ and Tissue Donor Serum Specimens
• HCV and HIV-1 RNA Stability: Effect of Anticoagulants and Long Term Storage at -20ºC and -70ºC
• Assessment of a Cross-supplemental Role for the Cobas Ampliscreen and PROCLEIX^® TMA HIV-1/HCV Assay Using Known RNA Control Samples
• Efficacy Assessment of the PROCLEIX^® dHIV-1 Assay in a Phase 3 Vaccine Clinical Trial
• Detection of HIV-1, HCV and HBV in Seroconversion Panels with the PROCLEIX^® ULTRIO^® Assay and ULTRIO Discriminatory Assays
• Validation of Alternative NAT HBV Assay: A Highly Sensitive PCR Based Assay for HBV DNA
• Simultaneous Screening for HIV-1, HCV and HBV in Blood Donations on with a High Throughput Fully Automated Instrument
• The PROCLEIX^® West Nile Virus Assay: Feasibility of the Automated TIGRIS™ System for Nucleic Acid Testing (NAT) of the West Nile Virus
• PROCLEIX^® West Nile Virus Assay: a Transcription-mediated Amplification Based Assay for Screening Blood donatons for West Nile Virus RNA
• Detection and Quantitation of West Nile Virus RNA by the Alternative NAT WNV Assay
• Development of a Transcription-mediated Amplification Based Assay for Detection of SARS Coronavirus